| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-46 |
| filingDate |
1994-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce30a4c726746f5c42d1745fef7d0e78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d35ac90edccdef815e0fe8323dbad80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7511bfa639ce8f826e108bf46aa70ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_209298a4c8c81653081be33f523df690 |
| publicationDate |
2003-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2175470-C |
| titleOfInvention |
Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide |
| abstract |
The present invention relates to a novel pharmaceutical composition for the preparation of a stable powder containing an association of acetylsalicylic acid and metoclopramid as the active ingredient. According to the invention, this composition comprises, as the active ingredient, an effective amount of a water-soluble salt or complex of acetylsalicylic acid in association with metoclopramid or one of its pharmaceutically acceptable salts, and at least one pharmaceutically acceptable hydrophilic polymer in a sufficient amount to stabilize the metoclopramid. This composition has a remarkable stability in powder form and can be used to prepare sachets for the treatment of migraine. |
| priorityDate |
1993-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |